VIR Latest Press Releases

-- October 28, 2026 --

Vir Biotechnology Announces Appointment of Suzanne Topalian to its Board of Directors Business Wire 8:30 AM

-- October 21, 2026 --

Vir Biotechnology to Host Conference Call for Third Quarter 2026 Financial Results Business Wire 4:05 PM

-- October 14, 2026 --

Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN Dual-masked T-cell Engagers for Solid Tumors Business Wire 8:30 AM

-- October 8, 2026 --

Vir Biotechnology Announces PSMA-targeted PRO-XTEN Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer Business Wire 8:30 AM

-- October 7, 2026 --

Vir Biotechnology Appoints David Liu as Chief Medical Officer Business Wire 8:30 AM

-- October 5, 2026 --

Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD's The Liver Meeting 2026 Business Wire 4:05 PM

-- October 1, 2026 --

Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer Business Wire 8:30 AM

-- August 31, 2026 --

Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Business Wire 4:05 PM

-- August 5, 2026 --

Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results Business Wire 4:05 PM

-- July 24, 2026 --

Vir Biotechnology Announces Chief Financial Officer Transition Business Wire 8:30 AM

-- July 22, 2026 --

Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results Business Wire 4:05 PM

-- June 10, 2026 --

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors Business Wire 4:05 PM

Market Data Delayed 15 Minutes